Bonspri Injection

Bonspri Injection contains the active ingredient Ofatumumab, belonging to the class of medicines known as monoclonal antibodies. It is indicated to treat adult patients having relapsing forms of multiple sclerosis (RMS). Inform your doctor if you have any immune system problems, cancer, or any severe infection or if you are planning on getting vaccinated before starting treatment with this medication. If you have or had hepatitis B infection, then inform your doctor before you start treatment with this medication as this medication might cause the hepatitis B virus to become active again.

Blood cancer (Chronic lymphocytic leukemia)

Bonspri Injection is to be used as prescribed by your healthcare provider. Do not self administer.

Bonspri Solution for Injection is a monoclonal antibody. It specifically binds to receptors on cancer cells. Thus it flags the cancer cells for destruction by the body's immune system.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Store below 30°C

1 PFS